Inverness Gets Financial Backing from GE Capital, UBS in Biosite Bid
 
Biosite said last week that Inverness Medical Innovations plans to buy the company with financial backing from General Electric Capital Corporation and UBS Loan Finance and Securities.
 
In a revised commitment letter Inverness sent to Biosite and disclosed last week, Biosite said that GECC and UBSS would loan Inverness $1.3 billion. GECC will provide 40 percent of the amount and UBSS will drum up the 60 percent balance.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.